As of November 6, 2026, MediWound Ltd. is a publicly traded company (Nasdaq: MDWD). The largest holder reporting an active stake on Schedule 13D is Access Industries, LLC, at 11.56%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include HOLD Alapkezelo Zrt. (10.4%), Rosalind Advisors, Inc. (7%), Yelin Lapidot Holdings Management Ltd. (5.95%) (Schedule 13D/A, October 3, 2025).
Is this your company?
About to sign with, pay or invest in MediWound Ltd.? See the free Snapshot first.
Free to see. No signup.
Is MediWound Ltd. a real, registered company?
- MediWound Ltd. files with the SEC under CIK 1593984 (its SEC filings).
- Its shares are listed under the ticker MDWD on Nasdaq (SEC company record).
- Incorporated in L3; business address in Yavne, L3, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under MediWound Ltd. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names HOLD Alapkezelo Zrt. (filed 2026-08-28).
Who are MediWound Ltd.'s owners and officers?
MediWound Ltd.: business address in Yavne, L3; industry Medicinal Chemicals & Botanical Products (Schedule 13G/A, 2026-08-28).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer (Form D, 2022-10-06)
- : Executive Officer (Form D, 2022-10-06)
- : Director (Form D, 2022-10-06)
- : Director (Form D, 2022-10-06)
- : Director (Form D, 2022-10-06)
- : Director (Form D, 2022-10-06)
- : Director (Form D, 2022-10-06)
- : Director (Form D, 2022-10-06)
- : Director (Form D, 2022-10-06)
- : Director (Form D, 2022-10-06)
- : Executive Officer (Form D, 2022-10-06)
- : Executive Officer, Director (Form D, 2022-10-06)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-28 | Hold Alapkezelo Zrt. | 10.4% |
| Schedule 13G/A, 2026-08-14 | T. Rowe Price Associates, Inc. | 5% |
| Schedule 13G, 2026-05-15 | T. Rowe Price Associates, Inc. | 5.5% |
| Schedule 13G/A, 2026-02-17 | T. Rowe Price Associates, Inc. | 4.3% |
| Schedule 13G/A, 2026-02-13 | Hold Alapkezelo Zrt. | 8.1% |
| Schedule 13G/A, 2026-02-11 | Rosalind Advisors, Inc. | 7% |
| Schedule 13G/A, 2026-02-05 | Yelin Lapidot Holdings Management LTD. | 5.95% |
| Schedule 13G, 2025-11-14 | T. Rowe Price Associates, Inc. | 5.5% |
| Schedule 13G/A, 2025-11-12 | Rosalind Advisors, Inc. | 7% |
| Schedule 13D/A, 2025-10-03 | Access Industries, LLC | 11.56% |
| Schedule 13G, 2025-09-19 | Hold Alapkezelo Zrt. | 6.5% |
| Schedule 13G/A, 2025-08-12 | Rosalind Advisors, Inc. | 5.2% |
Questions about who owns MediWound Ltd.
Who owns MediWound Ltd.?
On this page, 5 holders' latest ownership filings report 5% or more of MediWound Ltd.: Access Industries, LLC (11.56%, Schedule 13D/A, filed 2025-10-03), Hold Alapkezelo Zrt. (10.4%, Schedule 13G/A, filed 2026-08-28), Rosalind Advisors, Inc. (7%, Schedule 13G/A, filed 2026-02-11), Yelin Lapidot Holdings Management LTD. (5.95%, Schedule 13G/A, filed 2026-02-05) and T. Rowe Price Associates, Inc. (5%, Schedule 13G/A, filed 2026-08-14).
Who are the largest shareholders of MediWound Ltd.?
By the share each holder's latest filing reports, the largest holders of MediWound Ltd. on this page are Access Industries, LLC (11.56%), Hold Alapkezelo Zrt. (10.4%) and Rosalind Advisors, Inc. (7%).
When did Access Industries, LLC buy into MediWound Ltd.?
The filings give report dates, not purchase dates. The earliest filing from Access Industries, LLC on this page is the Schedule 13D/A, filed 2025-10-03, reporting 11.56%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on MediWound Ltd.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on MediWound Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on MediWound Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
20 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own MediWound Ltd. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- Nachum (Homi) Shamir, a director: 55,815 shares (0.43% of shares outstanding) (Form 4, 2026-06-04).
- , a director: 22,283 shares (0.17% of shares outstanding) (Form 4, 2026-06-02).
- , the chief executive: 8,900 shares (0.07% of shares outstanding) (Form 3, 2026-03-18).
- , the chief financial officer: 3,200 shares (0.02% of shares outstanding) (Form 3, 2026-03-18).
- , the general counsel and executive vice president: 1,850 shares (0.01% of shares outstanding) (Form 3, 2026-03-18).
Shares outstanding: 12,835,148 as of 2025-12-31, from the company's latest SEC cover page.
How much has MediWound Ltd. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2022-10-06 | $17.24M | $17.24M |
| Form D, 2022-10-04 | $13.26M | $13.26M |
Keep reading
More on MediWound Ltd. and the records around it.
MediWound Ltd. elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- HOLD Alapkezelo Zrt. also filed stake reports on 2 other companies: PERMA FIX ENVIRONMENTAL SERVICES INC (Oct 2026), Protalix BioTherapeutics, Inc. (Oct 2026)
- Yelin Lapidot Holdings Management Ltd. also filed stake reports on 3 other companies: Ellomay Capital Ltd. (Jul 2026), Enlight Renewable Energy Ltd. (Feb 2026), GILAT SATELLITE NETWORKS LTD (Feb 2026)
- Rosalind Advisors, Inc. also filed stake reports on 11 other companies: DELCATH SYSTEMS, INC. (Oct 2026), FEMASYS INC (Aug 2026), FENNEC PHARMACEUTICALS INC. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/mediwound